Literature DB >> 13693217

Body fluid and electrolyte composition in arterial hypertension. II. Studies in mineralocorticoid hypertension.

A V CHOBANIAN, B A BURROWS, W HOLLANDER.   

Abstract

Entities:  

Keywords:  ALDOSTERONE; BODY FLUIDS; ELECTROLYTES/metabolism; HYPERTENSION/physiology

Mesh：

Substances：

Year:  1961        PMID： 13693217      PMCID： PMC290735          DOI： 10.1172/JCI104269

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

1.  Body fluid and electrolyte composition in arterial hypertension. I. Studies in essential, renal and malignant hypertension.

Authors:  W HOLLANDER; A V CHOBANIAN; B A BURROWS
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

2.  Interrelations of plasma potassium concentration, plasma sodium concentration, arterial pH and total exchangeable potassium.

Authors:  J LEIBMAN; I S EDELMAN
Journal:  J Clin Invest       Date:  1959-12       Impact factor: 14.808

3.  Studies with Na22: an assessment of sodium balance and distribution.

Authors:  M M MARTIN; G WALKER
Journal:  Metabolism       Date:  1957-09       Impact factor: 8.694

4.  [Significance of common salt in desoxycorticosterone induced hypertension in rats and role in content of pressor substances in the kidney].

Authors:  F GROSS; P LOUSTALOT; F SULSER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1956

5.  Body sodium and potassium. II. A comparison of metabolic balance and isotope dilution methods of study.

Authors:  G M WILSON; J M OLNEY; L BROOKS; J A MYRDEN; M R BALL; F D MOORE
Journal:  Metabolism       Date:  1954-07       Impact factor: 8.694

6.  Malignant Hypertension Produced by Treatment with Desoxycorticosterone Acetate and Sodium Chloride.

Authors:  H Selye; C E Hall; E M Rowley
Journal:  Can Med Assoc J       Date:  1943-08       Impact factor: 8.262
  6 in total
  10 in total

Review 1.  ALDOSTERONE IN CLINICAL MEDICINE.

Authors:  E G BIGLIERI; P E SLATON
Journal:  Calif Med       Date:  1964-09

2.  PRIMARY ALDOSTERONISM: DIAGNOSIS AND SURGICAL TREATMENT.

Authors:  J W GILBERT; N H BELL; F C BARTTER
Journal:  Ann Surg       Date:  1963-08       Impact factor: 12.969

3.  Body fluid and electrolyte composition in arterial hypertension. I. Studies in essential, renal and malignant hypertension.

Authors:  W HOLLANDER; A V CHOBANIAN; B A BURROWS
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

4.  [Studies on the mechanism of the pressor effect of mineralocorticoids. I. Influence of 9 alpha-fluorohydrocortisone on the pressor effect of tyramine, noradrenaline, and angiotensin, on blood volume, and on plasma renin concentration (author's transl)].

Authors:  A Distler; H Liebau
Journal:  Klin Wochenschr       Date:  1973-11-15

5.  [Haemodynamic studies on the blood pressure-raising effect of mineralocorticoids (author's transl)].

Authors:  A Distler; T Philipp
Journal:  Klin Wochenschr       Date:  1979-11-02

Review 6.  Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift.

Authors:  L H White; T D Bradley; A G Logan
Journal:  J Hum Hypertens       Date:  2014-10-23       Impact factor: 3.012

Review 7.  Evolution of diagnostic criteria for primary aldosteronism: why is it more common in "drug-resistant" hypertension today?

Authors:  Clarence E Grim
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

8.  Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.

Authors:  E N Ehrlich; M D Lindheimer
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

9.  Captopril before and after spironolactone therapy in primary aldosteronism. Pathogenetic and therapeutical aspects.

Authors:  M Stimpel; W Vetter; H Groth; P Greminger; H Vetter
Journal:  Klin Wochenschr       Date:  1985-04-15

10.  Conventional Vasopressor and Vasopressor-Sparing Strategies to Counteract the Blood Pressure-Lowering Effect of Small Interfering RNA Targeting Angiotensinogen.

Authors:  Estrellita Uijl; Dien Ye; Liwei Ren; Katrina M Mirabito Colafella; Richard van Veghel; Ingrid M Garrelds; Hong S Lu; Alan Daugherty; Ewout J Hoorn; Paul Nioi; Don Foster; A H Jan Danser
Journal:  J Am Heart Assoc       Date:  2022-07-25       Impact factor: 6.106
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.